New research conducted at the Ingham Institute for Applied Medical Research in Liverpool, New South Wales, has found a new approach to treating pancreatic cancer. The research, published in Oncotarget, […]
Targeting an enzyme may provide metabolic treatment for pancreatic cancer
A new study released by our 2016-17 Seed Grant Awardee, Nada Kalaany, PhD shows evidence that targeting an enzyme that tumors use to get rid of nitrogen can slow tumor growth. These innovative therapeutic strategies are precisely why our Seed Grant Program is crucial in the fight against pancreatic cancer.
Chemotherapy nanoparticles offer breakthrough in pancreatic cancer drug delivery
Originally published at http://www.cancer.ucla.edu UCLA scientists combine a peptide with a nano cancer drug formulation to improve treatment effectiveness and prevent metastasis in pancreatic cancer Study shows the peptide enhances a […]
Study Explains Genetic Connection Between Aging and Cancer
David Gius, MD, PhD from Northwestern University was funded in the 2012 cycle of the Hirshberg Foundation’s annual Seed Grant Program. The results of the study explain the genetic connection […]
Hirshberg Funded International Researcher Publishes Findings
2011 Seed Grant Recipient Ido Wolf, MD from University of Tel Aviv, Israel, recently published his findings that will offer novel approaches towards development of new therapies for pancreatic cancer. […]
EPC Hirshberg Award Winners Announced
At the 48th meeting of the European Pancreatic Club, held this past June 8, 2016, in Liverpool, winners of the Hirshberg Awards were presented by one of the leading pancreatic […]